Allaire JJ, Xie Y, McPherson J, et al. 2022 rmarkdown: dynamic documents for R. R package version 2.19. (https://rmarkdown.rstudio.com)
Barrett T, Wilhite SE, Ledoux P, et al. 2013 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. https://doi.org/10.1093/nar/gks1193
Berkel C 2023 Estrogen receptor- and progesterone receptor-positive breast tumors have higher mRNA levels of NR3C1 and ZBTB16, with implications in prognosis for luminal A subtype. Hum. Cell. 37 376
Article CAS PubMed Google Scholar
Berkel C and Cacan E 2020 In silico analysis of DYNLL1 expression in ovarian cancer chemoresistance. Cell Biol. Int. 44 1598–1605
Article CAS PubMed Google Scholar
Berkel C and Cacan E 2021 Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer. Hum. Cell 34 862–877
Article CAS PubMed Google Scholar
Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L 2016 Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat. Rev. Clin. Oncol. 13 674–690
Blakeman V, Williams JL, Meng QJ, et al. 2016 Circadian clocks and breast cancer. Breast Cancer Res. 18 89
Article PubMed PubMed Central Google Scholar
Cadenas C, van de Sandt L, Edlund K, et al. 2014 Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle 13 3282–3291
Article CAS PubMed PubMed Central Google Scholar
Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, et al. 2013 The Cancer Genome Atlas Pan-Cancer Analysis project. Nat. Genet. 45 1113–1120
Article PubMed Central Google Scholar
Chen ST, Choo KB, Hou MF, et al. 2005 Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26 1241–1246
Article CAS PubMed Google Scholar
Dai X, Chen A and Bai Z 2014 Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling. Sci. Rep. 23 6566
Dunnwald LK, Rossing MA and Li CI 2007 Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 9 R6
Article PubMed PubMed Central Google Scholar
Gentleman RC, Carey VJ, Bates DM, et al. 2004 Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5 R80
Article PubMed PubMed Central Google Scholar
Gery S, Virk RK, Chumakov K, et al. 2007 The clock gene PER2 links the circadian system to the estrogen receptor. Oncogene 26 7916–7920
Article CAS PubMed Google Scholar
Győrffy B 2021 Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput. Struct. Biotechnol. J. 19 4101–4109
Article CAS PubMed PubMed Central Google Scholar
Hadadi E, Taylor W, Li XM, et al. 2020 Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice. Nat. Commun. 11 3193
Article CAS PubMed PubMed Central Google Scholar
He PJ, Hirata M, Yamauchi N, et al. 2007 Up-regulation of PER1 expression by estradiol and progesterone in the rat uterus. J. Endocrinol. 194 511–519
Article CAS PubMed Google Scholar
Hudis CA and Gianni L 2011 Triple-negative breast cancer: an unmet medical need. Oncologist 16 1–11
Iannone R, Cheng J, Schloerke B, et al. 2022 _gt: easily create presentation-ready display tables_. R package version 0.8.0, (https://CRAN.R-project.org/package=gt)
Kassambara A 2022 ggpubr: 'ggplot2' based publication ready plots_. R package version 0.5.0 (https://CRAN.R-project.org/package=ggpubr)
Kavakli IH, Baris I, Tardu M, et al. 2017 The photolyase/cryptochrome family of proteins as DNA repair enzymes and transcriptional repressors. Photochem. Photobiol. 93 93–103
Article CAS PubMed Google Scholar
Lesicka M, Jabłońska E, Wieczorek E, et al. 2018 Altered circadian genes expression in breast cancer tissue according to the clinical characteristics. PLoS One 13 e0199622
Article PubMed PubMed Central Google Scholar
Li J, Chen Z, Su K, et al. 2015 Clinicopathological classification and traditional prognostic indicators of breast cancer. Int. J. Clin. Exp. Pathol. 8 8500–8505
PubMed PubMed Central Google Scholar
Masood S 1992 Estrogen and progesterone receptors in cytology: a comprehensive review. Diagn. Cytopathol. 8 475–491
Article CAS PubMed Google Scholar
Morgan M and Shepherd L 2022 AnnotationHub: Client to access AnnotationHub resources_. R package version 3.4.0
Morgan M and Shepherd L 2022 ExperimentHub: Client to access ExperimentHub resources_. R package version 2.4.0
Morgan M, Obenchain V, Hester J et al. 2022 SummarizedExperiment: SummarizedExperiment container_. R package version 1.26.1 (https://bioconductor.org/packages/SummarizedExperiment)
Nakamura TJ, Moriya T, Inoue S, et al. 2005 Estrogen differentially regulates expression of PER1 and PER2 genes between central and peripheral clocks and between reproductive and nonreproductive tissues in female rats. J. Neurosci. Res. 82 622–630
Article CAS PubMed Google Scholar
Nakamura TJ, Sellix MT, Menaker M, et al. 2008 Estrogen directly modulates circadian rhythms of PER2 expression in the uterus. Am. J. Physiol. Endocrinol. Metab. 295 E1025–E1031
Article CAS PubMed PubMed Central Google Scholar
Nelson N, Lombardo J, Matlack L, et al. 2022 Chronoradiobiology of breast cancer: the time is now to link circadian rhythm and radiation biology. Int. J. Mol. Sci. 23 1331
Article CAS PubMed PubMed Central Google Scholar
Numata M, Hirano A, Yamamoto Y, et al. 2021 Metastasis of breast cancer promoted by circadian rhythm disruption due to light/dark shift and its prevention by dietary quercetin in mice. J. Circadian Rhythms 19 2
Article PubMed PubMed Central Google Scholar
Oh TG, Wang SM, Acharya BR, et al. 2016 The nuclear receptor, RORγ, regulates pathways necessary for breast cancer metastasis. eBioMedicine 6 59–72
Ooms J 2021 magick: Advanced graphics and image-processing in R_. R package version 2.7.3, (https://CRAN.R-project.org/package=magick)
Perrin JS, Segall LA, Harbour VL, et al. 2006 The expression of the clock protein PER2 in the limbic forebrain is modulated by the estrous cycle. Proc. Natl. Acad. Sci. USA 103 5591–5596
Article CAS PubMed PubMed Central Google Scholar
Putti TC, El-Rehim DM, Rakha EA, et al. 2005 Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod. Pathol. 18 26–35
Article CAS PubMed Google Scholar
R Core Team 2022 R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (https://www.R-project.org/)
Rahman M, Jackson LK, Johnson WE, et al. 2015 Alternative preprocessing of RNA-sequencing data in The Cancer Genome Atlas leads to improved analysis results. Bioinformatics 31 3666–3672
Article CAS PubMed PubMed Central Google Scholar
Rossetti S, Esposito J, Corlazzoli F, et al. 2012 Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes. Cell Cycle 11 350–360
Article CAS PubMed PubMed Central Google Scholar
Rubel CA, Lanz RB, Kommagani R, et al. 2012 Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. Mol. Endocrinol. 26 1428–1442
Article CAS PubMed PubMed Central Google Scholar
Sjoberg DD, Whiting K, Curry M, et al. 2021 Reproducible summary tables with the gtsummary package. R J. 13 570–580
Comments (0)